Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Paul Bianchi, Peter Rigby, Jorge Reis-Filho, Martin Bobrow, Chris Holmes, Martin Verhoef, Peter Honkanen


Illumina has named Paul Bianchi as its senior vice president of human resources. In his new role, Bianchi will oversee Illumina's global HR strategy and will manage the San Diego firm's office in Hayward, Calif.

Bianchi joins Illumina from Risk Management Solutions, where he was senior vice president of human resources. He has 20 years' experience at various companies.

Bianchi holds a master degree in management from the University of Kent in Canterbury, UK, and a BSc in managerial economics from the University of California, Davis.

Oxford Gene Technology has formed a scientific advisory board that will include Peter Rigby, who will serve as the board's chair, Jorge Reis-Filho, Martin Bobrow, and Chris Holmes.

Rigby is emeritus professor of developmental biology at the Institute of Cancer Research and deputy chairman of the board of governors at the Wellcome Trust. Reis-Filho is a professor of molecular pathology at ICR, and soon will join the Memorial Sloan-Kettering Cancer Center. Bobrow formerly was head of medical genetics at Guy's Hospital and he was deputy chairman of the Wellcome Trust and of the Nuffield Council on Bioethics. Holmes is a professor of biostatistics at the University of Oxford, head of statistical genetics at the Wellcome Trust Center for Human Genetics, and an elected member of council of the Royal Statistical Society.

Aushon BioSystems has appointed Martin Verhoef to be company CEO and to serve on its board of directors. Verhoef takes over the position from company founder Peter Honkanen, who will assume the post of chief operating officer and will continue as a board director.

Verhoef has spent 25 years in the life science research tools and molecular diagnostics business. He formerly was CEO at MiraDx and PrimeraDx, he led Ciphergen's Biosystems Division, and he held senior management jobs at Agilent in Germany and in the US.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.